Related Experiment Video
Updated: Feb 14, 2026

A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice
Published on: July 15, 2025
Industry-corrupted psychiatric trials
Jay D Amsterdam1, Leemon B McHenry2, Jon N Jureidini3
1Depression Research Unit, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Abstract:
The goal of this paper is to expose the research misconduct of pharmaceutical industry sponsored clinical trials via three short case studies of corrupted psychiatric trials that were conducted in the United States. We discuss the common elements that enable the misrepresentation of clinical trial results including ghostwriting for medical journals, the role of key opinion leaders as co-conspirators with the pharmaceutical industry and the complicity of top medical journals in failing to uphold standards of science and peer review. We conclude that the corruption of industry-sponsored clinical trials is one of the major obstacles facing evidence-based medicine.
Insights
This study exposes pharmaceutical industry misconduct in clinical trials. Key opinion leaders and top journals aided in misrepresenting psychiatric trial results, hindering evidence-based medicine.
Area of Science:
- Medical Research Ethics
- Clinical Trial Integrity
- Pharmaceutical Industry Oversight
Background:
- Pharmaceutical industry-sponsored clinical trials are crucial for medical advancements.
- Concerns exist regarding potential biases and misconduct in industry-funded research.
- Ensuring the integrity of clinical trial data is paramount for patient safety and effective treatments.
Purpose of the Study:
- To expose research misconduct in pharmaceutical industry-sponsored clinical trials.
- To analyze common elements facilitating the misrepresentation of trial results.
- To highlight the impact of misconduct on evidence-based medicine.
Main Methods:
- Case study analysis of three corrupted psychiatric clinical trials conducted in the United States.
- Examination of common misconduct elements: ghostwriting, key opinion leader involvement, and journal complicity.
- Review of scientific and peer-review standards in top medical journals.
Main Results:
- Identified ghostwriting in medical journals as a method for misrepresenting trial outcomes.
- Highlighted the role of key opinion leaders as collaborators with the pharmaceutical industry.
- Documented the complicity of leading medical journals in failing to maintain scientific standards.
Conclusions:
- The corruption of pharmaceutical industry-sponsored clinical trials poses a significant threat to evidence-based medicine.
- Misconduct in clinical trials undermines public trust in medical research.
- Stricter oversight and adherence to scientific standards are necessary to ensure trial integrity.
More Related Videos
Related Concept Videos
Trial and Error and Algorithm
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Microorganisms in Agriculture and Food industry
Statistical Software for Data Analysis and Clinical Trials
Global Climate Change

